Back to announcement
20250502_INAF_Penyampaian Bukti Iklan_31881731_lamp3.pdf
Other Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 20
Page 1
Go To English Page
Nomor Surat 0598/DIR/IV/2025
Nama Perusahaan Indofarma Tbk.
Kode Emiten INAF
Lampiran 3
Perihal Penyampaian Laporan Tahunan & Keberlanjutan dan ESG
Perseroan Menyampaikan Laporan Tahunan & Keberlanjutan dan ESG tahun 2024 dengan periode tahun buku dari
01 Januari 2024 sampai dengan 31 Desember 2024 dalam bahasa Indonesia dan Inggris
Apakah Perseroan akan/telah melakukan panggilan Rapat Umum Pemegang Saham Tahunan? (Ya)
Perseroan melakukan panggilan Rapat Umum Pemegang Saham Tahunan pada tanggal 03 Juni 2025
Informasi sebagaimana dimaksud di atas telah dimuat pada Situs Web Perseroan di alamat link www.indofarma.id
pada tanggal 03 Juni 2025
Apakah Perseroan tercatat di Bursa lain? (Tidak)
A. Kinerja Lingkungan (Environmental Performance)
Perseroan menyampaikan Keberlanjutan dan ESG Tahunan :
E-01 Laporan Emisi Gas Rumah Kaca (GRK)
Laporan Emisi GRK Konsolidasi? Tidak
Batasan Organisasi Operasional/Finansial
Adakah anak perusahaan yang tidak diikutsertakan dalam
Tidak
laporan ini?
Name Total Emisi (tCO2e)
Kategori 1: Emisi GRK langsung dan pembuangan
Emisi langsung dari pembakaran stasioner 103,9594
Emisi langsung dari pembakaran bergerak 0
Emisi langsung dari proses pengolahan 0
Emisi fugitive langsung 0
Emisi langsung dari Land Use, Land Use Change and
0
Forestry (LULUCF)
Total Emisi Langsung (Scope 1) 103,9594
Page 2
Kategori 2: Emisi GRK tidak langsung dari energi yang diimpor/dibeli
Emisi tidak langsung dari konsumsi Listrik yang
5.717,6888
diimpor/dibeli
Emisi tidak langsung dari konsumsi jaringan energi yang
0
diimpor/dibeli (diluar listrik)
Total Emisi Tidak Langsung (Scope 2) 5.717,6888
Kategori 3: Emisi GRK tidak langsung dari transportasi
Transportasi dan distribusi hulu 0
Perjalanan dinas 0
Transportasi dari klien dan pengunjung 0
Transportasi dan distribusi hilir 0
Perjalanan Karyawan 0
Kategori 4: Emisi GRK tidak langsung dari produk yang digunakan oleh perusahaan
Kegiatan yang berhubungan dengan energi yang tidak
termasuk dalam emisi langsung dan emisi energi tidak 0
langsung
Pembelian Barang dan Jasa 0
Capital equipment/goods 0
Limbah yang dihasilkan dalam kegiatan operasional 0,991
Aset Sewaan hulu 0
Kategori 5: Emisi GRK tidak langsung yang terkait dengan penggunaan produk dari perusahaan
Investasi 0
Penggunaan produk yang dijual 0
Perawatan akhir masa pakai produk yang dijual 0
Waralaba hilir 0
Aset Sewaan Hilir 0
Pengolahan produk yang dijual 0
Page 3
Kategori 6: Emisi GRK tidak langsung dari sumber lainnya
Emisi atau pembuangan tidak langsung lainnya 0
Total Emisi Tidak Langsung (Scope 3) 5.717,6888
Total Emisi GRK (Scope 1 and 2) 5.821,6482
Total Emisi GRK (Scope 1, 2 and 3) 5.822,6392
Offsets/Credits 0
Pembelian Renewable Energy Certificate (REC) (kWh) 0
Total emisi dari Scope 1 dan 2 per unit
E-02 Intensitas Emisi GRK 0
pendapatan Perusahaan Tercatat
Jumlah total energi yang dikonsumsi secara
6.572.056,09
langsung (kWh or J)
Jumlah total energi yang dikonsumsi secara
E-03 Konsumsi Energi listrik 0
tidak langsung (kWh or J))
Total konsumsi energi (kWh or J) 6.572.056,09
E-04 Konsumsi Air Total konsumsi air (m3) 16.840,8
E-05 Limbah yang dihasilkan Total limbah yang dihasilkan (ton) 0,82613
E-06 Komitmen Perusahaan untuk mencapai target Net Zero Emission
Apakah Perusahaan memiliki komitmen pencapaian target net zero? Tidak
Tahun berapa Perusahaan menargetkan pencapaian Net Zero emission yang
null
dipublikasi?
Mohon berikan deskripsi ringkas penjelasan dan tautan ke dokumentasi yang menjelaskan komitmen
pencapaian target Net zero emission Perusahaan.
null
E-07 Komitmen Perusahaan untuk mengurangi Emisi Gas Rumah Kaca (Emission Reduction)
Apakah Perusahaan memiliki komitmen mengurangi emisi? Tidak
0%
Target pengurangan emisi GRK
0 (tCO2e)
Tahun target untuk penurunan emisi GRK? null
Apakah perusahaan memiliki manajemen yang mengawasi pengendalian iklim?
Tidak
Langkah-langkah yang sudah dilakukan dan penurunan emisi yang telah dicapai dibandingkan tahun
sebelumnya.
Penjelasan:
Page 4
null
B. Kinerja Sosial (Social Performance)
S-01 Kesetaraan Gender
Laki-Laki Perempuan
Level Jabatan
Jumlah pegawai Persentasi pegawai Jumlah pegawai Persentasi pegawai
Entry-level 270 51.92 % 86 16.54 %
Mid-level 70 13.46 % 39 16.54 %
Senior-level 25 4.81 % 20 3.85 %
Executive-level 9 1.73 % 1 0.19 %
Total Pegawai 374 71.92 % 146 71.92 %
S-02 Jumlah level pegawai yang dimiliki oleh laki-laki dan perempuan berdasarkan kelompok umur
Level Jabatan
Rentang Usia Entry-level Mid-level Senior-level Executive-level Jumlah
(tahun) Pegawai
Laki-Laki Perempuan Laki-Laki Perempuan Laki-Laki Perempuan Laki-Laki Perempuan
18-25 0 0 0 0 0 0 0 0 0
25-35 28 23 0 16 0 0 0 0 67
35-45 87 23 17 9 9 10 1 1 157
45-55 112 31 46 11 13 9 8 0 230
>55 57 6 7 3 3 1 0 0 77
S-03 Tingkat Pergantian Pegawai
Jumlah Pegawai (dalam tahun Percentage Pegawai (dalam tahun
pelaporan) pelaporan)
Jumlah Pegawai
resign/Pemutusan Hubungan 39 Pegawai 8%
Kerja
Jumlah Pegawai Baru/pengganti 0 Pegawai 0%
S-04 Jumlah Pegawai Sementara
Jumlah Pegawai (dalam tahun Percentage Pegawai (dalam tahun
pelaporan) pelaporan)
Jumlah Pegawai perusahaan
yang dipegang oleh kontraktor 235 Pegawai 45 %
dan/atau konsultan
S-05 Pelatihan dan Pengembangan Pegawai
Page 5
Rata-rata jam pelatihan per
Jumlah pegawai yang ikut serta Persentase jumlah pegawai yang
pegawai dalam tahun
dalam program pelatihan ikut serta dalam pelatihan (%)
Pelaporan
20,9557 jam/pegawai 2.414 22 %
S-06 Jumlah Kecelakaan Kerja
Persentase kecelakaan kerja serius yang berakibat
Frekuensi kecelakaan kerja dari total pegawai
cedera serius dan fatal dari total pegawai (%)
0 0%
S-07 Jumlah Kejadian Pelanggaran Hak Asasi Manusia
Jumlah pelanggaran hak asasi manusia dalam tahun
0
Pelaporan
Kebijakan Perusahaan terkait Pekerja
S-08 Perusahaan memiliki kebijakan terkait pelecehan seksual dan/atau
Ya
non-diskriminasi?
TATA KELOLA PERUSAHAAN PT INDOFARMA
T B
w. Keselamatan Dan Kesempatan K
Kerja Serta Pelestarian Lingkungan (K3PL)
2.b. Perusahaan wajib menyediakan lingkungan kerja yang bebas dari segala bentuk tekanan (pelecehan)
yang mungkin timbul sebagai akibat perbedaan watak, keadaan pribadi dan latar belakang kebudayaan
seseorang.
S-09 Perusahaan memiliki kebijakan mengenai hak asasi manusia? Ya
Peraturan Direksi PT. Biofarma Persero, No PER-001.10/DIR/I/2024, Tanggal 10 Januari 2024
Kebijakan Berprilaku Saling Menghargai di Tempat Kerja di Holding BUMN Farmasi
S-10 Perusahaan memiliki kebijakan mengenai pekerja anak dan/atau
Ya
pekerja paksa?
Peraturan Direksi PT. Biofarma Persero, No PER-001.10/DIR/I/2024, Tanggal 10 Januari 2024
Kebijakan Berprilaku Saling Menghargai di Tempat Kerja di Holding BUMN Farmasi
S-11 Perusahaan memiliki kebijakan perusahaan mengenai kesehatan dan
keselamatan kerja serta lingkungan kerja yang aman dan layak diberikan Ya
kepada seluruh karyawan?
Kebijakan Sistem Manajemen Keselamatan Kesehatan Kerja, Tanggal 09 Desember 2021
Corporate Social Responsibility (CSR)
S-12 Perusahaan memiliki aktivitas CSR, investasi atau sumbangan
Ya
terhadap komunitas atau organisasi nirlaba terdaftar?
https://www.instagram.com/p/DHs0hnSyIyK/?igsh=eW8zOHF3YTdsYzQy
https://indofarma.id/2024/01/17/pt-indofarma-tbk-bersama-sma-avicenna-cinere-selenggarakan-pelayanan-
kesehatan-dan-pengobatan-gratis-di-wilayah-bogor/
https://www.instagram.com/p/C1wPFyZPwD2/?igsh=YjdhMXgzOTBianF1
https://www.instagram.com/reel/Cx5ehyxvZBc/?igsh=MWljaHNibjIycWo0Mg==
C. Kinerja Tata Kelola (Governance Performance)
Page 6
G-01 Keberagaman Manajemen dan Independensi (Board Diversity and Independence)
Tipe Manajemen
Jumlah Laki-laki Perempuan Pihak Independen
Perusahaan
Komisaris 0 2 0 1
Direksi 0 1 1 0
G-02 Total kehadiran direksi dan komisaris ke rapat dewan
Jumlah rapat dewan (di tahun Rata-rata persentase kehadiran
pelaporan) direksi/komisaris dalam rapat dewan
Jumlah kehadiran direksi ke rapat
12 100 %
dewan
Jumlah kehadiran komisaris ke
12 100 %
rapat dewan
Kebijakan mengenai manajemen lainnya
G-03 Perusahaan memiliki kebijakan mengenai pemisahan Chairman of
Ya
The Board dan CEO?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Board Manual (Charter Direksi & Charter Dewan Komisaris)
G-04 Perusahaan memiliki kebijakan penilaian dewan direksi dan
Tidak
komisaris
Direksi adalah: Kontak Manajemen
Komisaris adalah :KPI Dewan Komisarin yang tertuang dalam rencana kerja anggaran tahunan Dewan
Komisaris
G-05 Perusahaan memiliki kebijakan pelatihan dewan direksi dan
Ya
komisaris
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Board Manual (Charter of Directors & Charter of Board of Commissioners)
Komisaris
BAB II Charter Direksi, 2.4 Program Peningkatan Kopetensi Direksi
Direksi
BAB III Charter Direksi, 3.4 Program Peningkatan Kopetensi Direksi
G-06 Kriteria khusus yang digunakan untuk pemilihan dewan direksi dan
Ya
komisaris
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Board Manual (Charter of Directors & Charter of Board of Commissioners)
Komisaris
BAB II Charter Direksi, 2.2 Ketentuan Jabatan Anggota Dewan Komisaris
Direksi
BAB III Charter Direksi, 3.2 Ketentuan Jabatan Anggota Direksi
G-07 Perusahaan memiliki kebijakan mengenai kode etik dan/atau anti-
Ya
korupsi?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
1. Perusahaan telah memiliki kebijakan Code of Conduct (Pedoman Etika Usaha dan Etika Perilaku) yang
Page 7
telah disahkan oleh Direksi dan Dewan Komisaris pada tanggal 31 Desember 2021
2 Perusahaan telah memiliki Kebijakan terkait anti Korupsi, antara lain :
.a Pengelolaan Whistle Blowing System
.i Surat Keputusan Direksi tentang Kebijakan Sistem Pelaporan Atas Dugaan Penyimpangan
.(Whistle Blowing System) No. 0733/DIR/SK/IX/2020 tgl 28 Sep 2020
ii. Ketentuan Umum Pelaksanaan Kebijakan Sistem Pelaporan Atas Dugaan Penyimpangan (Whistle
Blowing System) No. XRM012 Rev 01 tgl 25 Okt 2022
b Pengelolaan Gratifikasi :
.i Surat Keputusan Direksi tentang Kebijakan Pengendalian Gratifikasi No. 0763/DIR/SK/X/2022
.tanggal 6 Oktober 2020
ii. Ketentuan Umum Pelaksanaan Kebijakan Pengendalian Gratifikasi No.XRM013 Rev 01 berlaku 22
Nov 2022
c Pengelolaan Pelaporan LHKPN (Laporan Hasil Kekayaan Penyelenggara Negara) ;
.Surat Keputusan Bersama Dewan Komisaris dan Direksi PT Indofarma Tbk No. SK-7/DK-INAF/10/2023 No.
0410/DIR/SK/X/2023 tanggal 2 Oktober 2023
d Pedoman Sistem Manajemen Anti Penyuapan (SMAP) ISO 37001 PT Indofarma Tbk Rev 02
.berlaku tanggal 7 April 2022.
G-08 Perusahaan memiliki kebijakan mengenai perlakuan adil terhadap
Ya
Pemegang Saham?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Tata Kelola Perusahaan PT. Indofarma Tbk
BAB II Prinsip Dasar GCG 2.2 Akuntabilitas & 2.5 Fairness (kewajaran)
G-09 Perusahaan memiliki kebijakan mengenai kewajiban
Ya
direksi/komisaris untuk mencegah adanya konflik kepentingan?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Board Manual dan Code of Corporate Governance
BAB III Charter Direksi, 3.11 Benturan Kepentingan
Page 8
D. Lain-lain
Keselarasan Laporan Keberlanjutan/Tahunan dengan Metrik ESG
Halaman di Laporan
Kinerja Kode Nama Metrik
Keberlanjutan/Tahunan
E-01 Laporan Emisi Gas Rumah Kaca 85
E-02 Intensitas Emisi Gas Rumah Kaca 85
E-03 Konsumsi Energi Listrik 85
E-04 Konsumsi Air 86
Lingkungan
E-05 Limbah yang Dihasilkan 87
Komitmen Perusahaan untuk Mencapai
E-06 n/a
Target Net Zero Emission
Komitmen Perusahaan untuk
E-07 n/a
mengurangi Emisi Gas Rumah Kaca
S-01 Kesetaraan Gender 94
Pegawai Berdasarkan Gender dan
S-02 94-95
Kelompok Umur
S-03 Tingkat Pergantian Pegawai 96
S-04 Jumlah Pegawai Sementara n/a
S-05 Pelatihan dan Pengembangan Pegawai 98
S-06 Jumlah Kecelakaan Kerja 102
Kejadian Pelanggaran Hak Asasi
S-07 122
Manusia
Sosial Kebijakan Pelecehan Seksual dan/atau
S-08 96
Non-diskriminasi
S-09 Kebijakan Mengenai Hak Asasi Manusia 122
Kebijakan Pekerja Anak dan/atau
S-10 140
Pekerja Paksa
Kebijakan Mengenai Kesehatan dan
Keselamatan Kerja serta Lingkungan
S-11 100
Kerja yang Aman dan Layak diberikan
Kepada Seluruh Karyawan
S-12 Pencegahan Konflik Kepentingan 106
Page 9
Keberagaman Manajemen dan
G-01 136
Independensi
Total Kehadiran Direksi dan Komisaris ke
G-02 144
Rapat Dewan
Kebijakan Pemisahan Chairman of the
G-03 213-215
Board dan CEO
Kebijakan Penilaian Dewan Direksi dan
G-04 147
Komisaris
Kebijakan Pelatihan Dewan Direksi dan
Tata-kelola G-05 144
Komisaris
G-06 Kriteria Khusus Pemilihan Dewan n/a
G-07 Kode Etik dan/atau Anti-Korupsi 207
Kebijakan Perlakuan Adil terhadap
G-08 n/a
Pemegang Saham
G-09 Pencegahan Konflik Kepentingan 202
Standar Internasional yang Diacu dan Verifikasi Pihak Ketiga
Keselarasan dengan kerangka pelaporan keberlanjutan
X Ya Tidak
X GRI
TCFD
CDP
IFRS S1
IFRS S2
SASB
X Others, please specify
P O J K
5 1
Assurance dan validasi pihak ketiga
X Ya
Nama pihak ketiga Lingkup pekerjaan
Demikian untuk diketahui.
Hormat Kami,
Indofarma Tbk.
Page 10
Hilda Yani
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Nama Pengirim Hilda Yani
Jabatan Corporate Secretary
Tanggal dan Waktu 30-04-2025 23:51
Lampiran 1. Penyampaian AR SR Tahun Buku 2024.pdf
2. INAF SR 2024 .pdf
3. 3_INAF AR 2024.pdf
Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 11
Go To Indonesian Page
Letter / Announcement No. 0598/DIR/IV/2025
Issuer Name Indofarma Tbk.
Issuer Code INAF
Attachment 3
Subject Submission of Annual And Sustainability Report
The Company hereby submit Annual And Sustainability Report Report 2024 for the period of 01 Januari 2024 to 31
Desember 2024 in Indonesia dan Inggris
Will the Company be/has summons for the Annual General Meeting of Shareholders? (Yes)
The Company made invitations to the Annual General Meeting of Shareholders on 03 Juni 2025
The information referred above has been published on the Company’s website www.indofarma.id at 03 Juni 2025
Is the Company listed on another Stock Exchange? (No)
A. Environmental Performance
The Company submits its Annual Sustainability and ESG Report:
E-01 Greenhouse Gas (GHG) Emission Report
Consolidated GHG Emission Report? No
Organizational Boundaries Operasional/Finansial
Any subsidiaries that are not included in the report? No
Name Total emission (tCO2e)
Category 1: Direct GHG emissions and removals
Direct emissions from stationary combustion 103,9594
Direct emissions from mobile combustion 0
Direct emissions from processes 0
Direct fugitive emissions 0
Direct emissions from Land Use, Land Use Change and
0
Forestry (LULUCF)
Total Direct Emissions (Scope 1) 103,9594
Category 2: Indirect GHG emissions from imported energy
Page 12
Indirect emissions from imported/purchased electricity
5.717,6888
consumption
Indirect emissions from imported/purchased network energy
0
consumption (excluding electricity)
Total Indirect Emissions (Scope 2) 5.717,6888
Category 3: Indirect GHG emissions from transportation
Upstream transport and distribution 0
Business travels 0
Transportation of clients and visitors 0
Downstream transportation and distribution 0
Employee commuting 0
Category 4: Indirect GHG emissions from products used by Organization
Energy related activities not included in direct emissions and
0
energy indirect emissions
Purchased goods and services 0
Capital equipment/goods 0
Waste generated in operations 0,991
Upstream leased assets 0
Category 5: Indirect GHG Emissions associated with the use of products from the Organization
Investments 0
Use of sold products 0
End of life treatment of sold products 0
Downstream franchises 0
Downstream leased assets 0
Processing of sold products 0
Category 6: Indirect GHG emissions from other sources
Page 13
Other indirect emissions or removals 0
Total GHG Emissions (Scope 1 and 2) 5.717,6888
Total GHG Emissions (Scope 1 and 2) 5.821,6482
Total GHG Emissions (Scope 1, 2 and 3) 5.822,6392
Offsets/Credits 0
REC Purchases (kWh) 0
Total scope 1 and 2 emissions produced per
E-02 GHG Emissions Intensity 0
revenue of listed compant (tCO2e/Rp)
Total amount of energy directly consumed
6.572.056,09
(kWh or J)
Total amount of energy indirectly consumed
E-03 Electricity Consumption 0
(kWh or J)
Total energy consumption (kWh or J) 6.572.056,09
E-04 Water Consumption Total water consumed (m3) 16.840,8
E-05 Waste Generation Total waste generated (ton) 0,82613
E-06 Company commitment to Net Zero Emission Target
Does the Company have a net zero emission target commitment? No
What year is the Company’s net zero emission published target? null
Please provide a brief description and a link to documentation explaining the Company’s commitment in
achieving net zero emission target.
null
E-07 Company Commitment to GHG Emission Reduction Target
Does the Company commit to reducing GHG emission? Tidak
0%
What is the Company’s GHG emission reduction target?
0 (tCO2e)
Targeted year in achieving GHG reduction target? null
Does the Listed Company has measures on monitoring in enacting climate policy?
No
Steps that have been taken and emission reductions that have been achieved compared to the previous year
Page 14
Efficient use of electricity and water in the work area both in the office and factory
Elimination of operational vehicles
Working time arrangements based on the Company's operational needs
B. Kinerja Sosial (Social Performance)
S-01 Gender Diversity
Men Women
Job positions Number of Percentage of Percentage of
Number of employees
employees employees employees
Entry-level 270 51.92 % 86 16.54 %
Mid-level 70 13.46 % 39 16.54 %
Senior-level 25 4.81 % 20 3.85 %
Executive-level 9 1.73 % 1 0.19 %
Total Pegawai 374 71.92 % 146 71.92 %
S-02 Employees Level by Gender and Age Group
Job levels
Age group Entry-level Mid-level Senior-level Executive-level Number of
(years) employees
Men Women Men Women Men Women Men Women
18-25 0 0 0 0 0 0 0 0 0
25-35 28 23 0 16 0 0 0 0 67
35-45 87 23 17 11 9 10 1 1 157
45-55 112 31 46 11 13 9 8 0 230
>55 57 6 7 3 3 1 0 0 77
S-03 Employees Turnover
Number of employees Percentage
(in reporting year) (in reporting year)
Number of employees resigned 39 Employees 8%
Number of newly appointed
0 Employees 0%
Employees
S-04 Temporary Worker
Number of employees Percentage
(in reporting year) (in reporting year)
Total company headcount held
by contractors and/or 235 Employees 45 %
consultants
S-05 Employee Training and Development
Page 15
Average training hour per
Total employee attending company Percentage of employee attending
employee
training program company training program (%)
(in reporting year)
20,9557 hours/employee 2.414 22 %
S-06 Injury Rate
Frequency of work-related accidents of total
Percentage of serious work-related accidents resulting in
Employees
serious and fatal injuries from total employees (%)
(in reporting year)
0 0%
S-07 Incidents Regarding Human Rights Abuse
Number of incidents regarding human rights
0
abuse (in reporting year)
Company Policy Regarding Employees
S-08 Does the company has a policy regarding sexual harassment and/or
Yes
non-discrimination?
S-09 Does the company has a policy regarding human rights? Yes
S-10 Does the company have a policy regarding child labor and/or forced
Yes
labor?
S-11 Does the company have a company policy regarding occupational
health and safety as well as a safe working environment for all Yes
employees?
Corporate Social Responsibility (CSR)
S-12 Does the company have CSR activities, investments or donations to
Yes
the community or registered non-profit organizations?
C. Governance Performance
G-01 Board Diversity and Independence
Type of Company Number of seats Seats Occupied by Seats Occupied by Seats Occupied by
Board on Company Men Women Independent Party
Page 16
Commissioners 0 2 0 1
Directors 0 1 1 0
G-02 Board Meeting Attendance
Number of board meetings Percentage of board meeting
(in reporting year) attendances (in reporting year)
Director Attendance to
12 100 %
Board Meetings
Comissioner Attendance to
12 100 %
Board Meetings
Other governmental-related policy
G-03 Does the company has a policy regarding separation of the
Yes
Chairman of the Board and CEO?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Board Manual (Charter of Directors & Charter of Board of Commissioners)
G-04 Does the company has a policy regarding board appraisal? No
The Board of Directors is the Management Contact
The Board of Commissioners is the KPI of the Board of Commissioners which is stated in the annual budget
work plan of the Board of Commissioners
G-05 Does the company has a policy regarding board training and
Yes
development?
Board Manual (Charter of Directors & Charter of Board of Commissioners)
Commissioner
CHAPTER II Charter of Directors, 2.4 Program for Improving the Competence of the Board of Directors
Board of Directors
CHAPTER III Charter of Directors, 3.4 Program for Improving the Competence of the Board of Directors
G-06 Does the company has a criteria regarding board appointment and
Yes
re-election?
Board Manual (Charter of Directors & Charter of Board of Commissioners)
Commissioners
CHAPTER II Charter of the Board of Directors, 2.2 Terms of Office of Members of the Board of
Commissioners
Board of Directors
CHAPTER III Charter of the Board of Directors, 3.2 Terms of Office of Members of the Board of
D i r e c t o r s
G-07 Does the company has a policy regarding ethics and/or anti-
Yes
corruption?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
1. The Company has a Code of Conduct policy (Business Ethics and Behavioral Ethics Guidelines) which
has been approved by the Board of Directors and Board of Commissioners on December 31, 2021
2. The Company has a Policy related to anti-Corruption, including:
a. Management of the Whistle Blowing System
i. Decree of the Board of Directors concerning the Policy on the Reporting System for Alleged Deviations
(Whistle Blowing System) No. 0733/DIR/SK/IX/2020 dated September 28, 2020
ii. General Provisions for the Implementation of the Policy on the Reporting System for Alleged Deviations
(Whistle Blowing System) No. XRM012 Rev 01 dated October 25, 2022
b. Gratification Management:
i. Decree of the Board of Directors concerning the Gratification Control Policy No. 0763/DIR/SK/X/2022
Page 17
dated October 6, 2020
ii. General Provisions for the Implementation of Gratification Control Policy No.XRM013 Rev 01 effective
November 22, 2022
c. Management of LHKPN Reporting (State Officials' Wealth Report);
Joint Decree of the Board of Commissioners and Directors of PT Indofarma Tbk No. SK-7/DK-INAF/10/2023
No. 0410/DIR/SK/X/2023 dated October 2, 2023
d. Guidelines for the ISO 37001 Anti-Bribery Management System (SMAP) of PT Indofarma Tbk Rev 02
effective April 7, 2022.
G-08 Does the company has a policy regarding equitable treatment of
Yes
shareholders?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Corporate Governance of PT. Indofarma Tbk
CHAPTER II Basic Principles of GCG 2.2 Accountability & 2.5 Fairness
G-09 Does the company have a policy regarding the obligations of
Yes
directors/commissioners to prevent conflicts of interest?
https://indofarma.id/tata-kelola-perusahaan-yang-baik/
Board Manual and Code of Corporate Governance
CHAPTER III Board of Directors Charter, 3.11 Conflict of Interest
Page 18
D. Other
Alignment of Sustainability/Annual Reports with ESG Metrics
Pages in the Sustainability/Annual
Kinerja Kode Metric Name
Report
E-01 Greenhouse Gas Emission Report 85
E-02 Greenhouse Gas Emission Intensity 85
E-03 Electricity Consumption 85
E-04 Water Consumption 86
Environment
E-05 Waste Generated 87
Company Commitment to Achieving Net
E-06 n/a
Zero Emission Target
Company Commitment to Reduce
E-07 n/a
Emission
S-01 Gender Equality 94
S-02 Employees by Gender and Age Group 94-95
S-03 Employee Turnover Rate 96
S-04 Number of Temporary Officers n/a
S-05 Employee Training and Development 98
S-06 Number of Work Accidents 102
S-07 Human Rights Violation Incidents 122
Social Sexual Harassment and/or Non-
S-08 96
Discrimination Policy
S-09 Policy on Human Rights 122
S-10 Child Labor and/or Forced Labor Policy 140
Occupational Health and Safety Policy
S-11 and Safe and Secure Work Environment 100
are provided to all employees.
S-12 Corporate Social Responsibility 106
Page 19
Management Diversity and
G-01 136
Independence
Total Attendance of Directors and
G-02 144
Commissioners to Board Meetings
Chairman of the Board and CEO
G-03 213-215
Separation Policy
Board of Directors and Commissioners
G-04 147
Assessment Policy
Board of Directors and Commissioners
Governance G-05 144
Training Policy
G-06 Special Criteria for Election of the Board n/a
G-07 Code of Ethics and/or Anti-Corruption 207
G-08 Fair Treatment Policy for Shareholders n/a
G-09 Conflict of Interest Prevention Policy 202
Referenced International Standards and Third Party Verification
Alignment with sustainability reporting framework
X Yes No
X GRI
TCFD
CDP
IFRS S1
IFRS S2
SASB
X Others, please specify
P O J K
5 1
Third-party assurance and/or validation
X Yes
Name of third-party service provider Scope of Work
Thus to be informed accordingly.
Respectfully,
Indofarma Tbk.
Page 20
Hilda Yani
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Sender Name Hilda Yani
Function Corporate Secretary
Date and Time 30-04-2025 23:51
Attachment 1. Penyampaian AR SR Tahun Buku 2024.pdf
2. INAF SR 2024 .pdf
3. 3_INAF AR 2024.pdf
This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
document.
Names mentioned 12 people and organisations named in the text · linked when the evidence is strong
unresolved
—
Emisi langsung dari pembakaran stasioner
p.1
unresolved
—
Emisi fugitive langsung
p.1
unresolved
—
Total Emisi Langsung (Scope 1)
p.1
unresolved
—
Direct emissions from stationary combustion
p.11
unresolved
—
Direct emissions from mobile combustion
p.11
unresolved
—
Direct emissions from processes
p.11
unresolved
—
Direct fugitive emissions
p.11
unresolved
—
Total Direct Emissions (Scope 1)
p.11
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.